Now doing business as Lundbeck Research USA, Inc the firm was previously called Neurogenetic Corporation, and then Synaptic Pharmaceutical Corporation is a biotechnology company engaged in the development of a broad platform of enabling technology, which it calls "human receptor-targeted drug design technology."Lundbeck Research USA, Inc. develops drugs for the treatment of various human disorders using its proprietary portfolio of G protein-coupled receptors. It discovers and clones genes, as well as designs G protein-coupled receptor agonists and antagonists. The company specializes in molecular biology, pharmacology, and medicinal chemistry. Lundbeck Research USA, Inc. was formerly known as Synaptic Pharmaceutical Corporation. As a result of the acquisition of Synaptic Pharmaceutical Corporation by H.Lundbeck A/S, Synaptic Pharmaceutical Corporation's name was changed. The company was founded in 1987 and is based in Paramus, New Jersey. As of March 6, 2003, Lundbeck Research USA, Inc. operates as a subsidiary of H.Lundbeck A/S.
